Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amber R Salter

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Multiple Sclerosis and Related Disorders|May 27, 2015
Impact of multiple sclerosis relapse: The NARCOMS participant perspectiveMolly Nickerson, Stacey S Cofield, Tuula Tyry, et al.
International Journal of MS Care|January 24, 2014
Natural history of multiple sclerosis symptomsIlya Kister, Tamar E Bacon, Eric Chamot, et al.
Neurology|July 1, 2016
Health insurance affects the use of disease-modifying therapy in multiple sclerosisGuoqiao Wang, Ruth Ann Marrie, Amber R Salter, et al.
Neurodegenerative Disease Management|November 28, 2015
Prevalence of multiple sclerosis symptoms across lifespan: data from the NARCOMS RegistryRobert J Fox, Tamar E Bacon, Eric Chamot, et al.
Multiple Sclerosis and Related Disorders|September 9, 2015
Causes of death among persons with multiple sclerosisGary R Cutter, Jeffrey Zimmerman, Amber R Salter, et al.
Patient Preference and Adherence|July 22, 2014
Patient perspectives on switching disease-modifying therapies in the NARCOMS registryAmber R Salter, Ruth Ann Marrie, Neetu Agashivala, et al.
Annals of Neurology|February 21, 2013
Randomized study combining interferon and glatiramer acetate in multiple sclerosisFred D Lublin, Stacey S Cofield, Gary R Cutter, et al.
Multiple Sclerosis and Related Disorders|November 17, 2017
Long-term follow-up of a randomized study of combination interferon and glatiramer acetate in multiple sclerosis: Efficacy and safety results up to 7 yearsFred D Lublin, Stacey S Cofield, Gary R Cutter, et al.
Journal of the Neurological Sciences|March 6, 2016
Relationship between symptom change, relapse activity and disability progression in multiple sclerosisYuliang Liu, Charity Morgan, Lindsey Hornung, et al.
Journal of Autism and Developmental Disorders|January 30, 2017
Assessment of Caregiver Inventory for Rett SyndromeJane B Lane, Amber R Salter, Nancy E Jones, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Multiple Sclerosis and Related Disorders|May 27, 2015
Impact of multiple sclerosis relapse: The NARCOMS participant perspectiveMolly Nickerson, Stacey S Cofield, Tuula Tyry, et al.
International Journal of MS Care|January 24, 2014
Natural history of multiple sclerosis symptomsIlya Kister, Tamar E Bacon, Eric Chamot, et al.
Neurology|July 1, 2016
Health insurance affects the use of disease-modifying therapy in multiple sclerosisGuoqiao Wang, Ruth Ann Marrie, Amber R Salter, et al.
Neurodegenerative Disease Management|November 28, 2015
Prevalence of multiple sclerosis symptoms across lifespan: data from the NARCOMS RegistryRobert J Fox, Tamar E Bacon, Eric Chamot, et al.
Multiple Sclerosis and Related Disorders|September 9, 2015
Causes of death among persons with multiple sclerosisGary R Cutter, Jeffrey Zimmerman, Amber R Salter, et al.
Patient Preference and Adherence|July 22, 2014
Patient perspectives on switching disease-modifying therapies in the NARCOMS registryAmber R Salter, Ruth Ann Marrie, Neetu Agashivala, et al.
Annals of Neurology|February 21, 2013
Randomized study combining interferon and glatiramer acetate in multiple sclerosisFred D Lublin, Stacey S Cofield, Gary R Cutter, et al.
Multiple Sclerosis and Related Disorders|November 17, 2017
Long-term follow-up of a randomized study of combination interferon and glatiramer acetate in multiple sclerosis: Efficacy and safety results up to 7 yearsFred D Lublin, Stacey S Cofield, Gary R Cutter, et al.
Journal of the Neurological Sciences|March 6, 2016
Relationship between symptom change, relapse activity and disability progression in multiple sclerosisYuliang Liu, Charity Morgan, Lindsey Hornung, et al.
Journal of Autism and Developmental Disorders|January 30, 2017
Assessment of Caregiver Inventory for Rett SyndromeJane B Lane, Amber R Salter, Nancy E Jones, et al.
Pageof 2